PA
NVO

Perennial Advisors’s Novo Nordisk NVO Stock Holding History

Perennial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-142
Closed -$3K – 220
2018
Q1 		$3K Hold
142
– – ﹤0.01% 190
2017
Q4 		$4K Hold
142
– – ﹤0.01% 189
2017
Q3 		$3K Hold
142
– – ﹤0.01% 187
2017
Q2 		$3K Hold
142
– – ﹤0.01% 194
2017
Q1 		$2K Hold
142
– – ﹤0.01% 174
2016
Q4 		$3K Buy
+142
New +$2.57K ﹤0.01% 188

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Perennial Advisors's NVO Position: Q2 2018 in Review

Perennial Advisors sold out of Novo Nordisk (NVO) in Q2 2018, closing a stake of 142 shares — an estimated $3K sold.

Perennial Advisors first reported a position in NVO in Q4 2016 and held it in 6 quarters. The position peaked at $4K in Q4 2017. 536 funds tracked by Wall St. Rank hold NVO as of Q2 2018.

  • Perennial Advisors reported no remaining Novo Nordisk position as of Q2 2018 after selling out during the quarter.
  • Perennial Advisors sold 142 Novo Nordisk shares in Q2 2018, an estimated $3K.
  • Perennial Advisors first reported a position in Novo Nordisk in Q4 2016 and held it in 6 quarters.
  • Perennial Advisors's Novo Nordisk position peaked at $4K in Q4 2017.
  • 536 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.

Based on Perennial Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.